123 related articles for article (PubMed ID: 12115575)
1. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
[TBL] [Abstract][Full Text] [Related]
2. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
[TBL] [Abstract][Full Text] [Related]
3. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
Engblom P; Rantanen V; Kulmala J; Helenius H; Grènman S
Br J Cancer; 1999 Jan; 79(2):286-92. PubMed ID: 9888470
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
Raitanen M; Rantanen V; Kulmala J; Pulkkinen J; Klemi P; Grénman S; Grénman R
Int J Cancer; 2002 Feb; 97(6):853-7. PubMed ID: 11857367
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
Erjala K; Raitanen M; Kulmala J; Grénman R
J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
[TBL] [Abstract][Full Text] [Related]
6. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
Pekkola-Heino K; Kulmala J; Grenman S; Carey TE; Grenman R
Cancer Res; 1989 Sep; 49(17):4876-8. PubMed ID: 2758419
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Grènman S
Cancer; 1999 Nov; 86(10):2066-73. PubMed ID: 10570433
[TBL] [Abstract][Full Text] [Related]
8. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro.
Zhang N; Erjala K; Kulmala J; Qiu X; Sundvall M; Elenius K; Grénman R
Radiother Oncol; 2009 Sep; 92(3):388-92. PubMed ID: 19447510
[TBL] [Abstract][Full Text] [Related]
10. In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y
Cancer Chemother Pharmacol; 1996; 37(6):525-30. PubMed ID: 8612305
[TBL] [Abstract][Full Text] [Related]
11. Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
Boabang P; Kurbacher CM; Kohlhagen H; Waida A; Amo-Takyi BK
Anticancer Drugs; 2000 Nov; 11(10):843-8. PubMed ID: 11142692
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
[TBL] [Abstract][Full Text] [Related]
13. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
Vihko KK; Seppänen M; Henttinen T; Punnonen J; Grénman S; Punnonen R
Cancer Immunol Immunother; 1997 Jan; 43(6):368-74. PubMed ID: 9067409
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
Engblom P; Rantanen V; Kulmala J; Grènman S
Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
[TBL] [Abstract][Full Text] [Related]
15. Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed?
Tsai CM; Chen JT; Stewart DJ; Chiu CH; Lai CL; Hsiao SY; Chen YM; Chang KT
J Thorac Oncol; 2011 Mar; 6(3):559-68. PubMed ID: 21258258
[TBL] [Abstract][Full Text] [Related]
16. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.
Kalemkerian GP; Ou X
Cancer Chemother Pharmacol; 1999; 43(2):145-50. PubMed ID: 9923820
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H
Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095
[TBL] [Abstract][Full Text] [Related]
18. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
Thigpen T; Vance RB; Khansur T
Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
[TBL] [Abstract][Full Text] [Related]
19. Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro.
Erjala K; Zhang N; Sundvall M; Kulmala J; Elenius K; Grénman R
Radiother Oncol; 2007 Oct; 85(1):138-45. PubMed ID: 17923163
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
